Prostatic Diseases  >>  flutamide  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
flutamide / Generic mfg.
NCT00817739: Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c

Completed
2
341
Europe
Leuprorelin, Flutamide
Takeda
Prostatic Neoplasms
09/05
12/08
NCT00283803: Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Completed
2
32
US
Exisulind, Aptosyn, luteinizing hormone-releasing hormone (LHRH) agonist, Lupron, Zoladex, Antiandrogen, Eulexin, Casodex
University of Washington, OSI Pharmaceuticals
Prostate Cancer
10/11
10/11
NCT00223665: Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer

Completed
2
102
US
Flutamide, Eulexin, Leuprolide Acetate, Lupron Depot, Eligard, Lupron
University of Washington, Sanofi
Prostate Cancer
09/12
09/12
NCT02341404 / 2011-001137-16: A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer

Completed
2
23
Europe
2-hydroxyflutamide (2-HOF), Liproca Depot
Lidds AB, Uppsala University
Prostate Cancer
05/15
05/15

Download Options